Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine Hemodynamics in POAG
NCT05474716Phase 4Completed
- Sponsor
- Fayoum University
- Start
- May 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine in primary open-angle glaucoma (POAG), sponsored by Fayoum University. Started May 2020; status: completed.
02
Drugs
brimonidine
03
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT05474716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05474716.